About Interventional Pulmonology
Interventional pulmonology is comparatively new in the field of pulmonary medicine. Interventional pulmonology used endoscopy and other various tools to diagnose and treat conditions in the lungs and chest. These procedures are majorly delivered by lung specialists. Interventional pulmonology is a relatively promising but quickly growing subspecialty across the United States. As the United States is primarily focused on advanced diagnostic and therapeutic procedures involving the airways, lungs, and pleura.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The market for Interventional Pulmonology is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Interventional Pulmonology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Argon Medical (United States), Body Vision Medical Ltd. (Israel), Boston Scientific Corporation (United States), C. R. Bard, Inc. (Becton, Dickinson and Company) (United States), CONMED Corporation (United States), ENDO-FLEX GmbH (Germany), Fujifilm Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Medtronic (Ireland) and Olympus Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Pennine Healthcare (United Kingdom), PENTAX Medical (Japan) and Pulmonx Corporation (United States).
Segmentation Overview
AMA Research has segmented the market of Global Interventional Pulmonology market by Type (Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves and Bronchial Thermoplasty Systems) and Region.
On the basis of geography, the market of Interventional Pulmonology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by End Users, the sub-segment i.e. Hospitals will boost the Interventional Pulmonology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indications, the sub-segment i.e. Asthma will boost the Interventional Pulmonology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Robotic Bronchoscopy is Emerging as a Game Changer in the Interventional Pulmonology Market
Market Growth Drivers:
Increase Occurrence of Respiratory Disorders across the Globe
Challenges:
Increase Concern Related to the Increasing Side Effects Concern Such as Bleeding, and Others
Restraints:
Lack of Awareness
Opportunities:
Strategic Acquisitions Help Expand Respiratory Portfolio, Accelerate Medical Processes
Market Leaders and their expansionary development strategies
On 4 December 2020, Olympus Corporation announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas (OCA) and will be the latest in a series of strategic acquisitions designed to strengthen Olympus' position as a leading global medical device company.
In 2021, World Health Organization published data, estimating that Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Interventional Pulmonology Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.